The International Journal of Tuberculosis and Lung Disease

Obstructive sleep apnoea in the elderly: a significant problem that needs urgent attention
pp. 715-717(3)
Authors: Oscullo, G.; Gomez-Olivas, J. D.; Martínez-García, M. Á.

An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines
pp. 718-720(3)
Authors: Nelson, K. N.; Shah, N. S.; Cranmer, L. M.; Vasudevan, L.; Bednarczyk, R. A.

Literature Highlights
pp. 721-723(3)
Authors: Trauer, J. M.; Tiberi, S.; Graham, S. M.; Blackbourn, H. D.

Clinical–radiological features and diagnostic modalities for mediastinal melioidosis
pp. 724-728(5)
Authors: Nyanti, L. E.; Lee, S. S. Y.; Shanmugam, V.; Muien, M. Z. bin Abdul; Othman, A. A.; Chia, Y. L.; Huan, N-C.; Ramarmuty, H. Y.; Kannan, K. K. Sivaraman

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease
pp. 729-741(13)
Authors: Visca, D.; Centis, R.; Pontali, E.; Zampogna, E.; Russell, A.-M.; Migliori, G. B.; Andrejak, C.; Aro, M.; Bayram, H.; Berkani, K.; Bruchfeld, J.; Chakaya, J. M.; Chorostowska-Wynimko, J.; Crestani, B.; Dalcolmo, M. P.; D’Ambrosio, L.; Dinh-Xuan, A-T.; Duong-Quy, S.; Fernandes, C.; García-García, J.-M.; de Melo Kawassaki, A; Carrozzi, L.; Martinez-Garcia, M. A.; Martins, P. Carreiro; Mirsaeidi, M.; Mohammad, Y.; Naidoo, R. N.; Neuparth, N.; Sese, L.; Silva, D. R.; Solovic, I.; Sooronbaev, T. M.; Spanevello, A.; Sverzellati, N.; Tanno, L.; Tiberi, S.; Vasankari, T.; Vasarmidi, E.; Vitacca, M.; Annesi-Maesano, I.

Establishing proof of concept for utility of Trueprep^®-extracted DNA in line-probe assay testing
pp. 742-747(6)
Authors: Rajendran, P.; Saini, S.; Kumar, N.; Vashistha, H.; Thiruvengadam, K.; Ramamoorthy, T.; Gopalaswamy, R.; Kayesth, J.; Alavadi, U.; Moore, M.; Joshi, R. P.; Ramachandran, R.; Anand, S.; Shanmugam, S.; Padmapriyadarsini, C.

Household drug-resistant TB contact tracing in Tajikistan
pp. 748-753(6)
Authors: Rekart, M. L.; Aung, A.; Cullip, T.; Mulanda, W.; Mun, L.; Pirmahmadzoda, B.; Kliescokova, J.; Achar, J.; Alvarez, J. L.; Sitali, N.; Sinha, A.

Adaptation and validation of a TB stigma scale for adolescents in Lima, Peru
pp. 754-760(7)
Authors: Chiang, S. S.; Zeng, C.; Roman-Sinche, B.; Altamirano, E.; Beckhorn, C. B.; Leon-Ostos, K.; Espinoza-Meza, R.; Lecca, L.; Franke, M. F.

Short-term exposure to air pollution and emergency room visits for acute respiratory symptoms among adults
pp. 761-765(5)
Authors: Yadav, R.; Nagori, A.; Madan, K.; Lodha, R.; Kabra, S. K.

Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK
pp. 766-771(6)
Authors: Andrews, F.; Welch, S.; Scandrett, K.; Kaur, H.; O’Shea, M. K.; Dedicoat, M.

Isoniazid and rifampicin exposure during treatment in drug-susceptible TB
pp. 772-777(6)
Authors: Akkerman, O. W.; Dijkwel, R. D. C.; Kerstjens, H. A. M.; van der Werf, T. S.; Srivastava, S.; Sturkenboom, M. G. G.; Bolhuis, M. S.

Adherence to treatment on a daily-dose regimen for TB
pp. 778-780(3)
Authors: Rajavardhana, T.; Koushik, M. R.; Jayakumar, C.; Ramalingam, P.; Geethavani, M.; Kumar, M. Ashok; Rajanandh, M. G.

Incidence of TB disease among persons who use drugs in California
pp. 781-783(3)
Authors: Frazier, C.; Nabity, S. A.; Flood, J.

Active case-finding for TB among incarcerated women in Peru
pp. 784-786(3)
Authors: Puma, D.; Geadas, C.; Calderon, R. I.; Yuen, C. M.; Jiménez, J.; CÓrdova, M.; Martínez, B.; Peinado, J.; Lecca, L.; Tovar, M.

Low rifampicin levels in plasma associated with a poor clinical response in patients with abdominal TB
pp. 787-789(3)
Authors: Singh, U. B.; Ray, Y.; Kanswal, S.; Sharma, H. P.; Aayilliath, A. K.; Wig, N.; Ahuja, V.; Biswas, A.; Velpandian, T.

A non-invasive, sensitive assay for active TB: combined cell-free DNA detection and FluoroSpot assays
pp. 790-792(3)
Authors: Kim, J. Y.; Koo, B.; Lim, S. Y.; Cha, H. H.; Kim, M. J.; Chong, Y. P.; Choi, S-H.; Lee, S-O.; Kim, Y. S.; Shin, Y.; Kim, S-H.